These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 19423276)
81. Growth-differentiation Factor-15 and Tissue Doppler Imaging in Detection of Anthracycline-induced Cardiomyopathy During Therapy of Childhood Cancers. Kaya F; Arslan D; Vatansev H; Kose D; Cimen D; Akyurek F; Oran B; Koksal Y J Pediatr Hematol Oncol; 2016 Apr; 38(3):e107-12. PubMed ID: 26907646 [TBL] [Abstract][Full Text] [Related]
82. Subclinical anthracycline therapy-related cardiac Dysfunction: an ignored stage B heart failure in an African population. Zhang WZ; Azibani F; Sliwa K Cardiovasc J Afr; 2020; 31(5):262-266. PubMed ID: 32628743 [TBL] [Abstract][Full Text] [Related]
83. [Usefulness of determining the blood levels of B-type natriuretic peptide in the evaluation of cardiotoxicity in children treated with anthracyclines]. Jackowska T; Wasilewski R Med Wieku Rozwoj; 2006; 10(3 Pt 1):767-74. PubMed ID: 17317907 [TBL] [Abstract][Full Text] [Related]
84. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. van Dalen EC; van der Pal HJ; Kok WE; Caron HN; Kremer LC Eur J Cancer; 2006 Dec; 42(18):3191-8. PubMed ID: 16987655 [TBL] [Abstract][Full Text] [Related]
85. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. Steinherz LJ; Steinherz PG; Tan C Med Pediatr Oncol; 1995 Jun; 24(6):352-61. PubMed ID: 7715541 [TBL] [Abstract][Full Text] [Related]
87. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy. Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328 [TBL] [Abstract][Full Text] [Related]
88. Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention. Adams MJ; Lipshultz SE Pediatr Blood Cancer; 2005 Jun; 44(7):600-6. PubMed ID: 15856486 [TBL] [Abstract][Full Text] [Related]
89. Anthracycline-induced cardiomyopathies evaluated by tissue Doppler tracking system and strain rate imaging. Takenaka K; Kuwada Y; Sonoda M; Uno K; Asakawa M; Sakurai S; Takahashi T; Sasaki K; Matsuzaki M; Kikuchi A; Amagai R; Furudate N; Nagai R J Cardiol; 2001; 37 Suppl 1():129-32. PubMed ID: 11433816 [TBL] [Abstract][Full Text] [Related]
90. Strategies for reduction of anthracycline cardiac toxicity. Speyer J; Wasserheit C Semin Oncol; 1998 Oct; 25(5):525-37. PubMed ID: 9783592 [TBL] [Abstract][Full Text] [Related]
91. Pathophysiology of anthracycline cardiotoxicity. Mele D; Tocchetti CG; Pagliaro P; Madonna R; Novo G; Pepe A; Zito C; Maurea N; Spallarossa P J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e3-e11. PubMed ID: 27755237 [TBL] [Abstract][Full Text] [Related]
92. Detection of anthracycline-induced cardiotoxicity: is there light at the end of the tunnel? Suter TM; Meier B Ann Oncol; 2002 May; 13(5):647-9. PubMed ID: 12075731 [No Abstract] [Full Text] [Related]
93. Decrease of Cardiac Base Rotation in 2D Speckle Tracking Indicates Drug-induced Cardiomyopathy After Chemotherapy in Children With Cancer. Yanagimoto K; Okamoto Y; Kodama Y; Nishikawa T; Tanabe T; Kawano Y J Pediatr Hematol Oncol; 2017 Jan; 39(1):10-14. PubMed ID: 27820133 [TBL] [Abstract][Full Text] [Related]
94. Pediatric AML patients with acute-onset cardiomyopathy in the setting of Streptococcus viridans bacteremia after anthracyclines. Sabet K; Panigrahi A; Chung J; Dayan Y Pediatr Blood Cancer; 2022 Feb; 69(2):e29450. PubMed ID: 34854543 [TBL] [Abstract][Full Text] [Related]
95. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Armenian SH; Hudson MM; Mulder RL; Chen MH; Constine LS; Dwyer M; Nathan PC; Tissing WJ; Shankar S; Sieswerda E; Skinner R; Steinberger J; van Dalen EC; van der Pal H; Wallace WH; Levitt G; Kremer LC; Lancet Oncol; 2015 Mar; 16(3):e123-36. PubMed ID: 25752563 [TBL] [Abstract][Full Text] [Related]
96. Ventricular late potentials: another expression of cardiotoxicity of cytostatic drugs in children? Tamminga RY; Bink-Boelkens MT; Kievit J Int J Cardiol; 1992 Sep; 36(3):283-8. PubMed ID: 1428262 [TBL] [Abstract][Full Text] [Related]
97. Anthracycline and Peripartum Cardiomyopathies. Cowgill JA; Francis SA; Sawyer DB Circ Res; 2019 May; 124(11):1633-1646. PubMed ID: 31120822 [TBL] [Abstract][Full Text] [Related]
98. Late echocardiographic findings following childhood chemotherapy with normal serial cardiac monitoring. Johnson GL; Moffett CB; Geil JD; Greenwood MF; Noonan JA J Pediatr Hematol Oncol; 1996 Feb; 18(1):72-5. PubMed ID: 8556375 [TBL] [Abstract][Full Text] [Related]
99. Cardiac Anthracycline Accumulation and B-Type Natriuretic Peptide to Define Risk and Predictors of Cancer Treatment-Related Early Diastolic Dysfunction. Minotti G; Salvatorelli E; Reggiardo G; Mangiacapra F; Camilli M; Menna P J Pharmacol Exp Ther; 2022 Jun; 381(3):266-273. PubMed ID: 35332076 [TBL] [Abstract][Full Text] [Related]